News Focus
News Focus
icon url

rosemountbomber

01/16/23 7:52 PM

#398453 RE: Whalatane #398451

Is there any way to find out definitively whether Amarin has stopped giving Vascepa to the Mitigate investigators?
icon url

shadolane

01/16/23 8:17 PM

#398456 RE: Whalatane #398451

Basically the reciprocal of your previous post.

Based on what we've experienced so far I'm guessing your previous post is more likely.

Guess we'll see sooner or later.
icon url

ramfan60

01/17/23 6:28 PM

#398573 RE: Whalatane #398451

Kiwi, here's my glass is just a glass view...

https://spotlight.kaiserpermanente.org/virtual-trial/#:~:text=The%20trial%2C%20called%20MITIGATE%2C%20will%20investigate%20whether%20a,respiratory%20illnesses%20in%20older%20adults%20with%20heart%20disease.

You keep putting waaaaaay too much emphasis on MITIGATE. There is only upside to MITIGATE, not downside....... this trial is not designed to determine event line separation in CVD patients. It's designed to see if V can also prevent or reduce the risk of complications from viral respiratory illnesses in older adults with heart disease. That's it...... PERIOD.